Antiretroviral News and Research

RSS

Bush administration is depriving millions access to life-saving generic drugs

AIDS Healthcare Foundation, has commended the World Health Organization (WHO) for their leadership and sincere interest in ensuring the safety of generic HIV/AIDS drugs in the developing world.

6 Aug 2004

Approval of fixed-dose combination treatments for HIV-1 infection

The Food and Drug Administration has announced the approvals of Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.

5 Aug 2004

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

The Food and Drug Administration has approved an injectable filler to correct facial fat loss in people with human immunodeficiency virus (HIV) infection.

5 Aug 2004

FDA approves two fixed-dose combination treatments for HIV-1 infection

The Food and Drug Administration has announced approved Epzicom (abacavir/lamivudine) and Truvada (tenofovir disoproxil/emtricitabine), two fixed-dose combination treatments for HIV-1 infection.

2 Aug 2004

Mining giant Rio Tinto has developed and implemented a global HIV/AIDS strategy

Rio Tinto’s response to HIV/AIDS draws upon the International Labour Organisation (ILO) Code of Good Practice on HIV/AIDS. Discrimination towards employees on the basis of real or perceived HIV status is not tolerated. The confidentiality of all information on the HIV status and condition of employees and community members is strictly upheld.

2 Aug 2004

Inexpensive generic three-in-one fixed-dose combination pill taken twice a day has helped HIV/AIDS patients in Uganda

The Arua Hospital AIDS Program today commemorated two years of providing free access to antiretroviral (ARV) treatment for nearly 1,100 people living with HIV/AIDS in Arua, a rural region in northwestern Uganda.

2 Aug 2004

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

Latin America still not faced a large-scale AIDS epidemic

Although the risk patterns that favor the expansion of HIV are very widespread, the majority of the countries of Latin America have still not faced a large-scale AIDS epidemic, according to a publication by the Pan American Health Organization and the World Bank.

26 Jul 2004

New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

The World Health Organization has published new guidelines underlining the effectiveness of antiretroviral drugs to prevent the transmission of HIV from seropositive mothers to their children.

15 Jul 2004

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

At the XVth International AIDS Conference in Bangkok, Thailand, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases and chief of the NIAID Laboratory of Immunoregulation (LIR), will present his laboratory’s latest findings on how aberrant immune activation underlies HIV pathogenesis.

15 Jul 2004

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

During the International AIDS Conference in Bangkok, IDA ARV Procurement Services BV and Clinton Foundation announced the agreement that enables developing countries to purchase high-quality AIDS medicines and diagnostics at the lowest available prices.

15 Jul 2004

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

At the international AIDS conference in Bangkok, AIDS Healthcare Foundation hosted a peaceful protest against British multinational pharmaceutical giant GlaxoSmithKline over its voluntary licensing of its AIDS drug patents in South Africa.

13 Jul 2004

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

A West African community has joined the network of community-based treatment support programs that form Bristol-Myers Squibb's real world field test of how HIV/AIDS treatment can best be combined with community-based care in some of the poorest and most remote areas of sub-Saharan Africa.

13 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

HIV patients treated with antiretroviral therapy early after infection do test negative

UCSF researchers have found that some HIV patients treated with antiretroviral therapy early after infection do test negative, at some point, for the virus. Study findings showed this result in six of 87 patients.

12 Jul 2004

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Increasing the body's production of growth hormone may be an effective treatment for HIV lipodystrophy, a syndrome involving the redistribution of fat and other metabolic changes in those receiving combination drug therapy for HIV infection.

11 Jul 2004

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Researchers at Johns Hopkins and University of Witwatersrand, South Africa, have determined that the actual average cost for providing primary care to an HIV-infected patient is $30 USD per visit.

11 Jul 2004

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Rapid testing during labor can enable pregnant women with undocumented HIV status to learn their HIV infection status so they can receive antiretroviral prophylaxis and be referred for comprehensive medical care and follow-up according to a report in the current issue of the Journal of the American Medical Association.

11 Jul 2004

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Results from a three year double-blinded trial which compared antiretroviral therapies show that the combination regimens of tenofovir DF and stavudine, are equally effective, though tenofovir DF has more favorable outcomes with respect to cholesterol levels and the nervous system.

11 Jul 2004

Nevirapine effective in reducing the risk of transmission of HIV at birth

A drug called nevirapine has been shown to be effective in reducing the risk of transmission of HIV at birth, but combination therapy of nevirapine and zidovudine does not improve outcomes, according to a study published in the current HIV/AIDS Journal of the American Medical Association.

11 Jul 2004

Antiretroviral News and Research

Bush administration is depriving millions access to life-saving generic drugs

Approval of fixed-dose combination treatments for HIV-1 infection

Approval of an injectable filler to correct facial fat loss in people with HIV/AIDS

FDA approves two fixed-dose combination treatments for HIV-1 infection

Mining giant Rio Tinto has developed and implemented a global HIV/AIDS strategy

Inexpensive generic three-in-one fixed-dose combination pill taken twice a day has helped HIV/AIDS patients in Uganda

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

Latin America still not faced a large-scale AIDS epidemic

New guidelines for antiretroviral drugs to prevent the transmission of HIV from mothers to their children

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Quality HIV/AIDS treatment eased through extended agreement about lowest-priced drugs and diagnostics

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV patients treated with antiretroviral therapy early after infection do test negative

Increasing levels of growth hormone may be an effective treatment for HIV lipodystrophy

Average cost for providing primary care to an HIV-infected patient is $30 USD per visit

Widespread prenatal HIV screening and use of antiretroviral drugs in pregnant HIV-infected women is needed

Comparison of antiretroviral therapies shows that tenofovir DF and stavudine are equally effective

Nevirapine effective in reducing the risk of transmission of HIV at birth

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News